nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—NR1I2—Rifampicin—leprosy	0.257	0.32	CbGbCtD
Docetaxel—SLCO1B3—Rifampicin—leprosy	0.101	0.126	CbGbCtD
Docetaxel—SLC22A7—Rifampicin—leprosy	0.0887	0.111	CbGbCtD
Docetaxel—ABCC1—Rifampicin—leprosy	0.0697	0.0868	CbGbCtD
Docetaxel—ABCC2—Rifampicin—leprosy	0.0516	0.0643	CbGbCtD
Docetaxel—CYP3A7—Rifampicin—leprosy	0.0344	0.0429	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0344	0.0429	CbGbCtD
Docetaxel—CYP3A7—Dapsone—leprosy	0.0284	0.0354	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0284	0.0354	CbGbCtD
Docetaxel—CYP3A5—Thalidomide—leprosy	0.0267	0.0332	CbGbCtD
Docetaxel—CYP3A5—Rifampicin—leprosy	0.0258	0.0322	CbGbCtD
Docetaxel—CYP3A5—Dapsone—leprosy	0.0213	0.0266	CbGbCtD
Docetaxel—ABCB1—Rifampicin—leprosy	0.0168	0.021	CbGbCtD
Docetaxel—CYP3A4—Rifampicin—leprosy	0.0101	0.0126	CbGbCtD
Docetaxel—CYP3A4—Dapsone—leprosy	0.00832	0.0104	CbGbCtD
Docetaxel—Acute myeloid leukaemia—Thalidomide—leprosy	0.0047	0.0403	CcSEcCtD
Docetaxel—Myelodysplastic syndrome—Thalidomide—leprosy	0.00384	0.033	CcSEcCtD
Docetaxel—Bronchopneumonia—Thalidomide—leprosy	0.00353	0.0303	CcSEcCtD
Docetaxel—TUBB—Menadione—Thalidomide—leprosy	0.00322	1	CbGdCrCtD
Docetaxel—Lymphoedema—Thalidomide—leprosy	0.00316	0.0271	CcSEcCtD
Docetaxel—MAP2—nerve—leprosy	0.00297	0.0553	CbGeAlD
Docetaxel—Gastrointestinal perforation—Thalidomide—leprosy	0.00295	0.0254	CcSEcCtD
Docetaxel—Thromboembolic event—Thalidomide—leprosy	0.00286	0.0246	CcSEcCtD
Docetaxel—Acute leukaemia—Thalidomide—leprosy	0.0027	0.0232	CcSEcCtD
Docetaxel—Lacrimal structural disorder—Thalidomide—leprosy	0.00262	0.0225	CcSEcCtD
Docetaxel—Polyneuropathy—Thalidomide—leprosy	0.00236	0.0203	CcSEcCtD
Docetaxel—KIF11—tendon—leprosy	0.00226	0.0422	CbGeAlD
Docetaxel—GHRHR—nervous system—leprosy	0.00216	0.0403	CbGeAlD
Docetaxel—TUBB4B—skin epidermis—leprosy	0.0021	0.0391	CbGeAlD
Docetaxel—KIF11—testis—leprosy	0.00187	0.0349	CbGeAlD
Docetaxel—Dysaesthesia—Thalidomide—leprosy	0.00178	0.0153	CcSEcCtD
Docetaxel—Lacrimal disorder—Thalidomide—leprosy	0.00172	0.0148	CcSEcCtD
Docetaxel—Ascites—Thalidomide—leprosy	0.0017	0.0146	CcSEcCtD
Docetaxel—Raised liver function tests—Thalidomide—leprosy	0.00167	0.0143	CcSEcCtD
Docetaxel—MAP4—eye—leprosy	0.00157	0.0294	CbGeAlD
Docetaxel—Lymphopenia—Thalidomide—leprosy	0.00151	0.0129	CcSEcCtD
Docetaxel—BCL2—IL2 signaling events mediated by STAT5—LTA—leprosy	0.00145	0.0599	CbGpPWpGaD
Docetaxel—Skin exfoliation—Dapsone—leprosy	0.00144	0.0124	CcSEcCtD
Docetaxel—MAP4—skin of body—leprosy	0.00137	0.0255	CbGeAlD
Docetaxel—Foetor hepaticus—Thalidomide—leprosy	0.00136	0.0117	CcSEcCtD
Docetaxel—MAPT—tendon—leprosy	0.00133	0.0247	CbGeAlD
Docetaxel—Febrile neutropenia—Thalidomide—leprosy	0.00128	0.011	CcSEcCtD
Docetaxel—Deep vein thrombosis—Thalidomide—leprosy	0.00127	0.0109	CcSEcCtD
Docetaxel—TUBB8—testis—leprosy	0.00126	0.0236	CbGeAlD
Docetaxel—BCL2—skin of body—leprosy	0.00124	0.0232	CbGeAlD
Docetaxel—TUBB8—nervous system—leprosy	0.00124	0.0232	CbGeAlD
Docetaxel—MAP2—eye—leprosy	0.00124	0.0231	CbGeAlD
Docetaxel—Oral candidiasis—Thalidomide—leprosy	0.00121	0.0104	CcSEcCtD
Docetaxel—Embolism—Thalidomide—leprosy	0.0012	0.0103	CcSEcCtD
Docetaxel—Nail disorder—Thalidomide—leprosy	0.00119	0.0102	CcSEcCtD
Docetaxel—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.00119	0.049	CbGpPWpGaD
Docetaxel—Intestinal obstruction—Thalidomide—leprosy	0.00113	0.00972	CcSEcCtD
Docetaxel—Liver disorder—Thalidomide—leprosy	0.00113	0.00972	CcSEcCtD
Docetaxel—Neuralgia—Thalidomide—leprosy	0.00111	0.00953	CcSEcCtD
Docetaxel—Burning sensation—Thalidomide—leprosy	0.00111	0.00953	CcSEcCtD
Docetaxel—MAPT—testis—leprosy	0.0011	0.0205	CbGeAlD
Docetaxel—Interstitial lung disease—Thalidomide—leprosy	0.00109	0.00936	CcSEcCtD
Docetaxel—MAP4—tendon—leprosy	0.00104	0.0194	CbGeAlD
Docetaxel—Neuritis—Thalidomide—leprosy	0.00103	0.00887	CcSEcCtD
Docetaxel—Pleural effusion—Thalidomide—leprosy	0.00101	0.00865	CcSEcCtD
Docetaxel—Nasopharyngitis—Dapsone—leprosy	0.000977	0.0084	CcSEcCtD
Docetaxel—Myocardial ischaemia—Thalidomide—leprosy	0.000959	0.00824	CcSEcCtD
Docetaxel—TUBB4A—eye—leprosy	0.000958	0.0179	CbGeAlD
Docetaxel—TUBB2B—eye—leprosy	0.000926	0.0173	CbGeAlD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TNFSF15—leprosy	0.000903	0.0373	CbGpPWpGaD
Docetaxel—Amenorrhoea—Thalidomide—leprosy	0.000877	0.00754	CcSEcCtD
Docetaxel—TUBB2A—eye—leprosy	0.000871	0.0163	CbGeAlD
Docetaxel—MAP4—testis—leprosy	0.000863	0.0161	CbGeAlD
Docetaxel—TUBB3—testis—leprosy	0.000863	0.0161	CbGeAlD
Docetaxel—Bone disorder—Thalidomide—leprosy	0.000853	0.00733	CcSEcCtD
Docetaxel—Hyperbilirubinaemia—Thalidomide—leprosy	0.000848	0.00728	CcSEcCtD
Docetaxel—MAP4—nervous system—leprosy	0.000847	0.0158	CbGeAlD
Docetaxel—TUBB3—nervous system—leprosy	0.000847	0.0158	CbGeAlD
Docetaxel—TUBB1—testis—leprosy	0.000844	0.0157	CbGeAlD
Docetaxel—Oliguria—Thalidomide—leprosy	0.000836	0.00719	CcSEcCtD
Docetaxel—TUBB4A—skin of body—leprosy	0.000833	0.0155	CbGeAlD
Docetaxel—Drug interaction—Thalidomide—leprosy	0.000831	0.00714	CcSEcCtD
Docetaxel—TUBB1—nervous system—leprosy	0.000828	0.0155	CbGeAlD
Docetaxel—Neuropathy peripheral—Dapsone—leprosy	0.000826	0.00709	CcSEcCtD
Docetaxel—MAP2—tendon—leprosy	0.000821	0.0153	CbGeAlD
Docetaxel—Hearing impaired—Thalidomide—leprosy	0.00081	0.00696	CcSEcCtD
Docetaxel—Bone pain—Thalidomide—leprosy	0.000805	0.00691	CcSEcCtD
Docetaxel—BCL2—testis—leprosy	0.000785	0.0146	CbGeAlD
Docetaxel—EGFR—testis—leprosy	0.000775	0.0145	CbGeAlD
Docetaxel—Hepatocellular injury—Thalidomide—leprosy	0.000771	0.00662	CcSEcCtD
Docetaxel—Pulmonary embolism—Thalidomide—leprosy	0.000771	0.00662	CcSEcCtD
Docetaxel—Phosphatase alkaline increased—Thalidomide—leprosy	0.000771	0.00662	CcSEcCtD
Docetaxel—BCL2—nervous system—leprosy	0.00077	0.0144	CbGeAlD
Docetaxel—TUBB2A—skin of body—leprosy	0.000758	0.0141	CbGeAlD
Docetaxel—Pharyngitis—Dapsone—leprosy	0.00075	0.00645	CcSEcCtD
Docetaxel—TUBB6—skin of body—leprosy	0.000748	0.014	CbGeAlD
Docetaxel—TUBB4B—eye—leprosy	0.000747	0.0139	CbGeAlD
Docetaxel—Colitis—Thalidomide—leprosy	0.00074	0.00636	CcSEcCtD
Docetaxel—Skin exfoliation—Thalidomide—leprosy	0.000736	0.00632	CcSEcCtD
Docetaxel—Candida infection—Thalidomide—leprosy	0.000736	0.00632	CcSEcCtD
Docetaxel—Neuropathy—Thalidomide—leprosy	0.000724	0.00622	CcSEcCtD
Docetaxel—Oesophagitis—Thalidomide—leprosy	0.000704	0.00605	CcSEcCtD
Docetaxel—Lightheadedness—Thalidomide—leprosy	0.00069	0.00593	CcSEcCtD
Docetaxel—Pulmonary oedema—Thalidomide—leprosy	0.000686	0.00589	CcSEcCtD
Docetaxel—MAP2—testis—leprosy	0.00068	0.0127	CbGeAlD
Docetaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—leprosy	0.000679	0.028	CbGpPWpGaD
Docetaxel—Sepsis—Thalidomide—leprosy	0.000669	0.00575	CcSEcCtD
Docetaxel—MAP2—nervous system—leprosy	0.000667	0.0124	CbGeAlD
Docetaxel—Erythema—Dapsone—leprosy	0.000658	0.00566	CcSEcCtD
Docetaxel—TUBB4B—skin of body—leprosy	0.00065	0.0121	CbGeAlD
Docetaxel—Thrombophlebitis—Thalidomide—leprosy	0.000646	0.00555	CcSEcCtD
Docetaxel—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000643	0.00553	CcSEcCtD
Docetaxel—BCL2—Apoptosis—LTA—leprosy	0.000637	0.0263	CbGpPWpGaD
Docetaxel—TUBB4A—tendon—leprosy	0.000634	0.0118	CbGeAlD
Docetaxel—Deafness—Thalidomide—leprosy	0.000625	0.00537	CcSEcCtD
Docetaxel—Cardiac failure congestive—Thalidomide—leprosy	0.000617	0.0053	CcSEcCtD
Docetaxel—TUBB2B—tendon—leprosy	0.000613	0.0114	CbGeAlD
Docetaxel—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.0006	0.0248	CbGpPWpGaD
Docetaxel—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.0006	0.0248	CbGpPWpGaD
Docetaxel—TUBB—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000594	0.0245	CbGpPWpGaD
Docetaxel—CYP1B1—eye—leprosy	0.000592	0.011	CbGeAlD
Docetaxel—Atrial fibrillation—Thalidomide—leprosy	0.00059	0.00507	CcSEcCtD
Docetaxel—Visual disturbance—Thalidomide—leprosy	0.00059	0.00507	CcSEcCtD
Docetaxel—SLC22A7—testis—leprosy	0.000588	0.011	CbGeAlD
Docetaxel—Dermatitis bullous—Thalidomide—leprosy	0.000585	0.00503	CcSEcCtD
Docetaxel—KIF11—MHC class II antigen presentation—HLA-DRB1—leprosy	0.000584	0.0241	CbGpPWpGaD
Docetaxel—TUBB—tendon—leprosy	0.00058	0.0108	CbGeAlD
Docetaxel—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000579	0.0239	CbGpPWpGaD
Docetaxel—TUBB2A—tendon—leprosy	0.000577	0.0108	CbGeAlD
Docetaxel—Cough—Dapsone—leprosy	0.000574	0.00493	CcSEcCtD
Docetaxel—Cardiac failure—Thalidomide—leprosy	0.000573	0.00493	CcSEcCtD
Docetaxel—Lethargy—Thalidomide—leprosy	0.000571	0.00491	CcSEcCtD
Docetaxel—TUBB6—tendon—leprosy	0.000569	0.0106	CbGeAlD
Docetaxel—Hyponatraemia—Thalidomide—leprosy	0.000562	0.00483	CcSEcCtD
Docetaxel—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000561	0.0232	CbGpPWpGaD
Docetaxel—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000559	0.00481	CcSEcCtD
Docetaxel—Pain in extremity—Thalidomide—leprosy	0.000559	0.00481	CcSEcCtD
Docetaxel—Migraine—Thalidomide—leprosy	0.000551	0.00473	CcSEcCtD
Docetaxel—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000548	0.0226	CbGpPWpGaD
Docetaxel—Ataxia—Thalidomide—leprosy	0.000526	0.00452	CcSEcCtD
Docetaxel—TUBB4A—testis—leprosy	0.000525	0.0098	CbGeAlD
Docetaxel—Tachycardia—Dapsone—leprosy	0.000524	0.0045	CcSEcCtD
Docetaxel—Dehydration—Thalidomide—leprosy	0.00052	0.00447	CcSEcCtD
Docetaxel—Liver function test abnormal—Thalidomide—leprosy	0.000517	0.00444	CcSEcCtD
Docetaxel—TUBB4A—nervous system—leprosy	0.000516	0.00962	CbGeAlD
Docetaxel—CYP1B1—skin of body—leprosy	0.000515	0.00961	CbGeAlD
Docetaxel—Dry skin—Thalidomide—leprosy	0.000513	0.00441	CcSEcCtD
Docetaxel—Orthostatic hypotension—Thalidomide—leprosy	0.000511	0.00439	CcSEcCtD
Docetaxel—TUBB2B—testis—leprosy	0.000508	0.00947	CbGeAlD
Docetaxel—Breast disorder—Thalidomide—leprosy	0.000506	0.00434	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000504	0.00433	CcSEcCtD
Docetaxel—Cramp muscle—Thalidomide—leprosy	0.000504	0.00433	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000504	0.00433	CcSEcCtD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—RIPK2—leprosy	0.000503	0.0208	CbGpPWpGaD
Docetaxel—BCL2—Validated targets of C-MYC transcriptional repression—SLC11A1—leprosy	0.000499	0.0206	CbGpPWpGaD
Docetaxel—ABCC10—tendon—leprosy	0.000498	0.0093	CbGeAlD
Docetaxel—TUBB2B—nervous system—leprosy	0.000498	0.0093	CbGeAlD
Docetaxel—TUBB4B—tendon—leprosy	0.000495	0.00923	CbGeAlD
Docetaxel—Alanine aminotransferase increased—Thalidomide—leprosy	0.000493	0.00424	CcSEcCtD
Docetaxel—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.000492	0.0203	CbGpPWpGaD
Docetaxel—Insomnia—Dapsone—leprosy	0.000486	0.00417	CcSEcCtD
Docetaxel—Dysphagia—Thalidomide—leprosy	0.000484	0.00415	CcSEcCtD
Docetaxel—TUBB—testis—leprosy	0.00048	0.00896	CbGeAlD
Docetaxel—TUBB2A—testis—leprosy	0.000478	0.00892	CbGeAlD
Docetaxel—Bronchospasm—Thalidomide—leprosy	0.000476	0.00409	CcSEcCtD
Docetaxel—TUBB6—testis—leprosy	0.000471	0.00879	CbGeAlD
Docetaxel—Angina pectoris—Thalidomide—leprosy	0.000471	0.00405	CcSEcCtD
Docetaxel—TUBB2A—nervous system—leprosy	0.000469	0.00875	CbGeAlD
Docetaxel—TUBB6—nervous system—leprosy	0.000463	0.00863	CbGeAlD
Docetaxel—Pancytopenia—Thalidomide—leprosy	0.000459	0.00395	CcSEcCtD
Docetaxel—Neutropenia—Thalidomide—leprosy	0.000452	0.00389	CcSEcCtD
Docetaxel—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.00045	0.0186	CbGpPWpGaD
Docetaxel—Weight increased—Thalidomide—leprosy	0.00044	0.00378	CcSEcCtD
Docetaxel—Gastrointestinal pain—Dapsone—leprosy	0.000439	0.00377	CcSEcCtD
Docetaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—leprosy	0.000438	0.0181	CbGpPWpGaD
Docetaxel—Weight decreased—Thalidomide—leprosy	0.000437	0.00376	CcSEcCtD
Docetaxel—Pneumonia—Thalidomide—leprosy	0.000434	0.00373	CcSEcCtD
Docetaxel—Infestation—Thalidomide—leprosy	0.000431	0.0037	CcSEcCtD
Docetaxel—Infestation NOS—Thalidomide—leprosy	0.000431	0.0037	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000427	0.00367	CcSEcCtD
Docetaxel—Acute coronary syndrome—Thalidomide—leprosy	0.000425	0.00365	CcSEcCtD
Docetaxel—Abdominal pain—Dapsone—leprosy	0.000425	0.00365	CcSEcCtD
Docetaxel—Body temperature increased—Dapsone—leprosy	0.000425	0.00365	CcSEcCtD
Docetaxel—Renal failure—Thalidomide—leprosy	0.000424	0.00364	CcSEcCtD
Docetaxel—Myocardial infarction—Thalidomide—leprosy	0.000423	0.00363	CcSEcCtD
Docetaxel—Neuropathy peripheral—Thalidomide—leprosy	0.000423	0.00363	CcSEcCtD
Docetaxel—Stomatitis—Thalidomide—leprosy	0.00042	0.00361	CcSEcCtD
Docetaxel—Conjunctivitis—Thalidomide—leprosy	0.000419	0.0036	CcSEcCtD
Docetaxel—ABCC10—testis—leprosy	0.000413	0.0077	CbGeAlD
Docetaxel—TUBB4B—testis—leprosy	0.00041	0.00764	CbGeAlD
Docetaxel—ABCB1—blood vessel—leprosy	0.000408	0.00762	CbGeAlD
Docetaxel—Epistaxis—Thalidomide—leprosy	0.000407	0.00349	CcSEcCtD
Docetaxel—Agranulocytosis—Thalidomide—leprosy	0.000402	0.00346	CcSEcCtD
Docetaxel—TUBB4B—nervous system—leprosy	0.000402	0.0075	CbGeAlD
Docetaxel—ABCC2—tendon—leprosy	0.0004	0.00747	CbGeAlD
Docetaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—leprosy	0.000397	0.0164	CbGpPWpGaD
Docetaxel—CYP1B1—tendon—leprosy	0.000392	0.00731	CbGeAlD
Docetaxel—MAP2—SIDS Susceptibility Pathways—IL10—leprosy	0.000392	0.0162	CbGpPWpGaD
Docetaxel—Rhinitis—Thalidomide—leprosy	0.000388	0.00333	CcSEcCtD
Docetaxel—Hepatitis—Thalidomide—leprosy	0.000387	0.00333	CcSEcCtD
Docetaxel—Hypoaesthesia—Thalidomide—leprosy	0.000385	0.00331	CcSEcCtD
Docetaxel—Pharyngitis—Thalidomide—leprosy	0.000384	0.0033	CcSEcCtD
Docetaxel—Urinary tract disorder—Thalidomide—leprosy	0.000382	0.00328	CcSEcCtD
Docetaxel—Oedema peripheral—Thalidomide—leprosy	0.000381	0.00328	CcSEcCtD
Docetaxel—Urethral disorder—Thalidomide—leprosy	0.000379	0.00326	CcSEcCtD
Docetaxel—Visual impairment—Thalidomide—leprosy	0.000373	0.0032	CcSEcCtD
Docetaxel—Erythema multiforme—Thalidomide—leprosy	0.000366	0.00314	CcSEcCtD
Docetaxel—Eye disorder—Thalidomide—leprosy	0.000362	0.00311	CcSEcCtD
Docetaxel—Cardiac disorder—Thalidomide—leprosy	0.000359	0.00309	CcSEcCtD
Docetaxel—ABCC1—tendon—leprosy	0.000352	0.00658	CbGeAlD
Docetaxel—Angiopathy—Thalidomide—leprosy	0.000351	0.00302	CcSEcCtD
Docetaxel—Immune system disorder—Thalidomide—leprosy	0.00035	0.003	CcSEcCtD
Docetaxel—Mediastinal disorder—Thalidomide—leprosy	0.000349	0.003	CcSEcCtD
Docetaxel—Chills—Thalidomide—leprosy	0.000347	0.00298	CcSEcCtD
Docetaxel—Arrhythmia—Thalidomide—leprosy	0.000346	0.00297	CcSEcCtD
Docetaxel—Alopecia—Thalidomide—leprosy	0.000342	0.00294	CcSEcCtD
Docetaxel—Vomiting—Dapsone—leprosy	0.000342	0.00293	CcSEcCtD
Docetaxel—MAPT—IL-5 Signaling Pathway—IL2—leprosy	0.000341	0.0141	CbGpPWpGaD
Docetaxel—Mental disorder—Thalidomide—leprosy	0.000339	0.00291	CcSEcCtD
Docetaxel—Malnutrition—Thalidomide—leprosy	0.000337	0.0029	CcSEcCtD
Docetaxel—Headache—Dapsone—leprosy	0.000336	0.00289	CcSEcCtD
Docetaxel—ABCC2—testis—leprosy	0.000331	0.00618	CbGeAlD
Docetaxel—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.00033	0.0136	CbGpPWpGaD
Docetaxel—Dysgeusia—Thalidomide—leprosy	0.00033	0.00284	CcSEcCtD
Docetaxel—MAPT—IL-2 Signaling Pathway—IL2—leprosy	0.000328	0.0135	CbGpPWpGaD
Docetaxel—Back pain—Thalidomide—leprosy	0.000326	0.0028	CcSEcCtD
Docetaxel—CYP1B1—testis—leprosy	0.000325	0.00605	CbGeAlD
Docetaxel—Muscle spasms—Thalidomide—leprosy	0.000324	0.00278	CcSEcCtD
Docetaxel—Nausea—Dapsone—leprosy	0.000319	0.00274	CcSEcCtD
Docetaxel—CYP1B1—nervous system—leprosy	0.000318	0.00594	CbGeAlD
Docetaxel—KIF11—Adaptive Immune System—PARK2—leprosy	0.000312	0.0129	CbGpPWpGaD
Docetaxel—Anaemia—Thalidomide—leprosy	0.000311	0.00268	CcSEcCtD
Docetaxel—Syncope—Thalidomide—leprosy	0.000302	0.0026	CcSEcCtD
Docetaxel—Leukopenia—Thalidomide—leprosy	0.000302	0.00259	CcSEcCtD
Docetaxel—Palpitations—Thalidomide—leprosy	0.000298	0.00256	CcSEcCtD
Docetaxel—Loss of consciousness—Thalidomide—leprosy	0.000296	0.00254	CcSEcCtD
Docetaxel—Cough—Thalidomide—leprosy	0.000294	0.00253	CcSEcCtD
Docetaxel—Convulsion—Thalidomide—leprosy	0.000292	0.00251	CcSEcCtD
Docetaxel—ABCC1—testis—leprosy	0.000292	0.00545	CbGeAlD
Docetaxel—Hypertension—Thalidomide—leprosy	0.000291	0.0025	CcSEcCtD
Docetaxel—Arthralgia—Thalidomide—leprosy	0.000287	0.00246	CcSEcCtD
Docetaxel—Myalgia—Thalidomide—leprosy	0.000287	0.00246	CcSEcCtD
Docetaxel—Chest pain—Thalidomide—leprosy	0.000287	0.00246	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000285	0.00245	CcSEcCtD
Docetaxel—Dry mouth—Thalidomide—leprosy	0.000281	0.00241	CcSEcCtD
Docetaxel—Confusional state—Thalidomide—leprosy	0.000277	0.00238	CcSEcCtD
Docetaxel—BCL2—Overview of nanoparticle effects—TNF—leprosy	0.000277	0.0114	CbGpPWpGaD
Docetaxel—Oedema—Thalidomide—leprosy	0.000275	0.00236	CcSEcCtD
Docetaxel—Infection—Thalidomide—leprosy	0.000273	0.00235	CcSEcCtD
Docetaxel—Shock—Thalidomide—leprosy	0.000271	0.00232	CcSEcCtD
Docetaxel—Nervous system disorder—Thalidomide—leprosy	0.00027	0.00232	CcSEcCtD
Docetaxel—Thrombocytopenia—Thalidomide—leprosy	0.000269	0.00231	CcSEcCtD
Docetaxel—Tachycardia—Thalidomide—leprosy	0.000268	0.00231	CcSEcCtD
Docetaxel—Skin disorder—Thalidomide—leprosy	0.000267	0.00229	CcSEcCtD
Docetaxel—BCL2—IL2 signaling events mediated by STAT5—IL2—leprosy	0.000264	0.0109	CbGpPWpGaD
Docetaxel—Anorexia—Thalidomide—leprosy	0.000262	0.00225	CcSEcCtD
Docetaxel—Hypotension—Thalidomide—leprosy	0.000257	0.00221	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Thalidomide—leprosy	0.000251	0.00215	CcSEcCtD
Docetaxel—Insomnia—Thalidomide—leprosy	0.000249	0.00214	CcSEcCtD
Docetaxel—Paraesthesia—Thalidomide—leprosy	0.000247	0.00212	CcSEcCtD
Docetaxel—Dyspnoea—Thalidomide—leprosy	0.000245	0.00211	CcSEcCtD
Docetaxel—Somnolence—Thalidomide—leprosy	0.000244	0.0021	CcSEcCtD
Docetaxel—Dyspepsia—Thalidomide—leprosy	0.000242	0.00208	CcSEcCtD
Docetaxel—ABCG2—testis—leprosy	0.000242	0.00451	CbGeAlD
Docetaxel—Decreased appetite—Thalidomide—leprosy	0.000239	0.00205	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Thalidomide—leprosy	0.000237	0.00204	CcSEcCtD
Docetaxel—Fatigue—Thalidomide—leprosy	0.000237	0.00204	CcSEcCtD
Docetaxel—Pain—Thalidomide—leprosy	0.000235	0.00202	CcSEcCtD
Docetaxel—Constipation—Thalidomide—leprosy	0.000235	0.00202	CcSEcCtD
Docetaxel—KIF11—Adaptive Immune System—RIPK2—leprosy	0.000227	0.00938	CbGpPWpGaD
Docetaxel—Feeling abnormal—Thalidomide—leprosy	0.000227	0.00195	CcSEcCtD
Docetaxel—Gastrointestinal pain—Thalidomide—leprosy	0.000225	0.00193	CcSEcCtD
Docetaxel—BCL2—IL2 signaling events mediated by PI3K—IL2—leprosy	0.000223	0.0092	CbGpPWpGaD
Docetaxel—Body temperature increased—Thalidomide—leprosy	0.000217	0.00187	CcSEcCtD
Docetaxel—Abdominal pain—Thalidomide—leprosy	0.000217	0.00187	CcSEcCtD
Docetaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—leprosy	0.000215	0.00889	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CYLD—leprosy	0.000214	0.00883	CbGpPWpGaD
Docetaxel—BCL2—IL-5 Signaling Pathway—IL2—leprosy	0.00021	0.00865	CbGpPWpGaD
Docetaxel—Hypersensitivity—Thalidomide—leprosy	0.000203	0.00174	CcSEcCtD
Docetaxel—BCL2—IL-2 Signaling Pathway—IL2—leprosy	0.000202	0.00832	CbGpPWpGaD
Docetaxel—Asthenia—Thalidomide—leprosy	0.000197	0.0017	CcSEcCtD
Docetaxel—Pruritus—Thalidomide—leprosy	0.000195	0.00167	CcSEcCtD
Docetaxel—KIF11—Immune System—PARK2—leprosy	0.000189	0.00781	CbGpPWpGaD
Docetaxel—Diarrhoea—Thalidomide—leprosy	0.000188	0.00162	CcSEcCtD
Docetaxel—BCL2—IL2-mediated signaling events—IFNG—leprosy	0.000185	0.00765	CbGpPWpGaD
Docetaxel—Dizziness—Thalidomide—leprosy	0.000182	0.00156	CcSEcCtD
Docetaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—leprosy	0.000178	0.00735	CbGpPWpGaD
Docetaxel—Vomiting—Thalidomide—leprosy	0.000175	0.0015	CcSEcCtD
Docetaxel—KIF11—Adaptive Immune System—CD40LG—leprosy	0.000174	0.00719	CbGpPWpGaD
Docetaxel—Rash—Thalidomide—leprosy	0.000173	0.00149	CcSEcCtD
Docetaxel—Dermatitis—Thalidomide—leprosy	0.000173	0.00149	CcSEcCtD
Docetaxel—BCL2—ATF-2 transcription factor network—IFNG—leprosy	0.000173	0.00713	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD8A—leprosy	0.000172	0.00711	CbGpPWpGaD
Docetaxel—Headache—Thalidomide—leprosy	0.000172	0.00148	CcSEcCtD
Docetaxel—ABCC10—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000169	0.00696	CbGpPWpGaD
Docetaxel—CYP3A4—nervous system—leprosy	0.000165	0.00308	CbGeAlD
Docetaxel—BCL2—IL2-mediated signaling events—IL2—leprosy	0.000165	0.0068	CbGpPWpGaD
Docetaxel—Nausea—Thalidomide—leprosy	0.000163	0.0014	CcSEcCtD
Docetaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—leprosy	0.000159	0.00656	CbGpPWpGaD
Docetaxel—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.00015	0.00619	CbGpPWpGaD
Docetaxel—MAP2—SIDS Susceptibility Pathways—TNF—leprosy	0.000149	0.00615	CbGpPWpGaD
Docetaxel—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—leprosy	0.000147	0.00606	CbGpPWpGaD
Docetaxel—MAPT—Alzheimers Disease—TNF—leprosy	0.000144	0.00594	CbGpPWpGaD
Docetaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000142	0.00588	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—HLA-DRB1—leprosy	0.00014	0.00579	CbGpPWpGaD
Docetaxel—KIF11—Immune System—RIPK2—leprosy	0.000138	0.00569	CbGpPWpGaD
Docetaxel—KIF11—Immune System—TLR2—leprosy	0.000138	0.00569	CbGpPWpGaD
Docetaxel—BCL2—Ceramide signaling pathway—TNF—leprosy	0.000132	0.00544	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.000128	0.00528	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—CD4—leprosy	0.000126	0.00519	CbGpPWpGaD
Docetaxel—KIF11—Immune System—NOD2—leprosy	0.000125	0.00516	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.000125	0.00515	CbGpPWpGaD
Docetaxel—ABCB1—testis—leprosy	0.000119	0.00222	CbGeAlD
Docetaxel—ABCB1—nervous system—leprosy	0.000117	0.00218	CbGeAlD
Docetaxel—BCL2—Caspase Cascade in Apoptosis—TNF—leprosy	0.000115	0.00474	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.000114	0.00469	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.000111	0.00457	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—IFNG—leprosy	0.000109	0.0045	CbGpPWpGaD
Docetaxel—BCL2—Corticotropin-releasing hormone—IL2—leprosy	0.000108	0.00444	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000107	0.0044	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000107	0.0044	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD40LG—leprosy	0.000106	0.00436	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—IL2—leprosy	0.000105	0.00435	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD8A—leprosy	0.000105	0.00431	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—IFNG—leprosy	0.000104	0.00427	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000103	0.00425	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—SLC11A1—leprosy	9.98e-05	0.00412	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—CD4—leprosy	9.9e-05	0.00408	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—SLC11A1—leprosy	9.76e-05	0.00403	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CYLD—leprosy	9.6e-05	0.00396	CbGpPWpGaD
Docetaxel—EGFR—SHP2 signaling—IL2—leprosy	9.2e-05	0.0038	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Telomerase—IFNG—leprosy	9.12e-05	0.00376	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—SLC11A1—leprosy	8.76e-05	0.00362	CbGpPWpGaD
Docetaxel—KIF11—Immune System—HLA-DRB1—leprosy	8.51e-05	0.00351	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—leprosy	8.43e-05	0.00348	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—TNF—leprosy	8.4e-05	0.00347	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	8.28e-05	0.00342	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—TNF—leprosy	8.28e-05	0.00342	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Telomerase—IL2—leprosy	8.1e-05	0.00334	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	8.07e-05	0.00333	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—TNF—leprosy	8.07e-05	0.00333	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—SLC11A1—leprosy	8.01e-05	0.00331	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TNF—leprosy	7.87e-05	0.00325	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—SLC11A1—leprosy	7.62e-05	0.00315	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RIPK2—leprosy	7.58e-05	0.00313	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—leprosy	7.24e-05	0.00299	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TNF—leprosy	7.11e-05	0.00293	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL10—leprosy	6.94e-05	0.00287	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CD40LG—leprosy	6.94e-05	0.00287	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—RIPK2—leprosy	6.41e-05	0.00265	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IFNG—leprosy	6.21e-05	0.00257	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—TLR2—leprosy	6.19e-05	0.00255	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—RIPK2—leprosy	6.19e-05	0.00255	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD4—leprosy	6e-05	0.00248	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IFNG—leprosy	5.87e-05	0.00242	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CYLD—leprosy	5.67e-05	0.00234	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—IL2—leprosy	5.66e-05	0.00234	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NOD2—leprosy	5.61e-05	0.00231	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CYLD—leprosy	5.59e-05	0.00231	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	5.59e-05	0.00231	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL2—leprosy	5.52e-05	0.00228	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL2—leprosy	5.21e-05	0.00215	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—SLC11A1—leprosy	5.18e-05	0.00214	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TNF—leprosy	5.16e-05	0.00213	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL2—leprosy	5.14e-05	0.00212	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—SLC11A1—leprosy	5.12e-05	0.00211	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PARK2—leprosy	4.94e-05	0.00204	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PARK2—leprosy	4.82e-05	0.00199	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SDHD—leprosy	4.51e-05	0.00186	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	4.5e-05	0.00186	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.37e-05	0.0018	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IFNG—leprosy	4.08e-05	0.00168	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TNF—leprosy	3.8e-05	0.00157	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR2—leprosy	3.66e-05	0.00151	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—RIPK2—leprosy	3.66e-05	0.00151	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL2—leprosy	3.63e-05	0.0015	CbGpPWpGaD
Docetaxel—BCL2—Immune System—RIPK2—leprosy	3.6e-05	0.00149	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR2—leprosy	3.6e-05	0.00149	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RIPK2—leprosy	3.51e-05	0.00145	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NOD2—leprosy	3.32e-05	0.00137	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CYLD—leprosy	3.31e-05	0.00136	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NOD2—leprosy	3.27e-05	0.00135	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SDHD—leprosy	3.19e-05	0.00132	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SDHD—leprosy	3.08e-05	0.00127	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL2—leprosy	3.04e-05	0.00125	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PARK2—leprosy	2.92e-05	0.00121	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—leprosy	2.86e-05	0.00118	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SLC11A1—leprosy	2.86e-05	0.00118	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SDHD—leprosy	2.81e-05	0.00116	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SDHD—leprosy	2.78e-05	0.00115	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD40LG—leprosy	2.76e-05	0.00114	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—leprosy	2.73e-05	0.00113	CbGpPWpGaD
Docetaxel—EGFR—Disease—SLC11A1—leprosy	2.7e-05	0.00111	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—leprosy	2.69e-05	0.00111	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD40LG—leprosy	2.69e-05	0.00111	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—leprosy	2.66e-05	0.0011	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—leprosy	2.64e-05	0.00109	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.58e-05	0.00107	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	2.43e-05	0.001	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DRB1—leprosy	2.22e-05	0.000918	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DRB1—leprosy	2.17e-05	0.000894	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RIPK2—leprosy	2.13e-05	0.000879	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR2—leprosy	2.13e-05	0.000879	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SDHD—leprosy	2.01e-05	0.00083	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NOD2—leprosy	1.93e-05	0.000797	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD40LG—leprosy	1.63e-05	0.000674	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFNG—leprosy	1.62e-05	0.00067	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—leprosy	1.61e-05	0.000666	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—leprosy	1.59e-05	0.000657	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—leprosy	1.57e-05	0.000647	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—leprosy	1.53e-05	0.000631	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SDHD—leprosy	1.52e-05	0.000626	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—leprosy	1.44e-05	0.000596	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RIPK2—leprosy	1.38e-05	0.000568	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DRB1—leprosy	1.31e-05	0.000542	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.3e-05	0.000538	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—leprosy	1.21e-05	0.000499	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—leprosy	9.6e-06	0.000396	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SDHD—leprosy	9.35e-06	0.000386	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—leprosy	9.34e-06	0.000385	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—leprosy	9.27e-06	0.000383	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—leprosy	9.08e-06	0.000375	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—leprosy	8.56e-06	0.000353	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—leprosy	8.53e-06	0.000352	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—leprosy	5.51e-06	0.000228	CbGpPWpGaD
